After 283 Days, Health Minister (Finally) Grants Psilocybin Exemptions To Three Canadians With Mental Health Conditions Dec 14, 2021
Awakn Life Sciences Appoints Former EVP & Chief Commercial Officer of Gilead Sciences, Paul Carter, as Independent… Dec 14, 2021
atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated… Dec 14, 2021
